These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21778370)

  • 1. AIDS research. Complexity surrounds HIV prevention advances.
    Cohen J
    Science; 2011 Jul; 333(6041):393. PubMed ID: 21778370
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.
    Cohen J
    Science; 2010 Dec; 330(6009):1298-9. PubMed ID: 21127220
    [No Abstract]   [Full Text] [Related]  

  • 3. CDC launches prevention efforts focused on PrEP, high-risk groups.
    AIDS Policy Law; 2015 May; 30(6):1, 4. PubMed ID: 26117851
    [No Abstract]   [Full Text] [Related]  

  • 4. Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance.
    Horberg M; Raymond B
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S125-8. PubMed ID: 23253752
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention. Using PrEP cost-effective in high-risk MSM groups.
    AIDS Policy Law; 2012 Jun; 27(7):1. PubMed ID: 22803211
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS research. FDA panel recommends anti-HIV drug for prevention.
    Cohen J
    Science; 2012 May; 336(6083):792. PubMed ID: 22605725
    [No Abstract]   [Full Text] [Related]  

  • 7. PrEP trial in women halted due to doubts that it could show efficacy.
    McEnery R
    IAVI Rep; 2011; 15(2):21. PubMed ID: 21608329
    [No Abstract]   [Full Text] [Related]  

  • 8. Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
    Coutinho B; Prasad R
    Am Fam Physician; 2013 Oct; 88(8):535-40. PubMed ID: 24364575
    [No Abstract]   [Full Text] [Related]  

  • 9. The new revolution: HIV prevention in a pill.
    Grant R
    Posit Aware; 2013; 25(5):2-5. PubMed ID: 25358197
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV pre-exposure prophylaxis.
    Morin SF; Yamey G; Rutherford GW
    BMJ; 2012 Aug; 345():e5412. PubMed ID: 22890030
    [No Abstract]   [Full Text] [Related]  

  • 11. Infectious diseases. Doubts dispelled about HIV prevention.
    Cohen J
    Science; 2015 Mar; 347(6226):1055-6. PubMed ID: 25745140
    [No Abstract]   [Full Text] [Related]  

  • 12. From professional to personal.
    Johnson AD
    Posit Aware; 2013; 25(5):6-7. PubMed ID: 25358198
    [No Abstract]   [Full Text] [Related]  

  • 13. PrEPPING for the future.
    Brooks J
    Posit Aware; 2013; 25(5):18-9. PubMed ID: 25358203
    [No Abstract]   [Full Text] [Related]  

  • 14. Second complete once-daily single tablet therapy in development.
    AIDS Patient Care STDS; 2009 Aug; 23(8):680. PubMed ID: 19694037
    [No Abstract]   [Full Text] [Related]  

  • 15. PrEP in the real world.
    Mastro TD
    Posit Aware; 2013; 25(5):8-9. PubMed ID: 25358199
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?
    Curran JW; Crosby RA
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S163-6. PubMed ID: 23253761
    [No Abstract]   [Full Text] [Related]  

  • 17. PrEP in practice.
    Wheeler D
    Posit Aware; 2013; 25(5):10-1. PubMed ID: 25358200
    [No Abstract]   [Full Text] [Related]  

  • 18. Pre-exposure prophylaxis for HIV: can it be implemented in the real world?
    Katz MH
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S161-2. PubMed ID: 23253760
    [No Abstract]   [Full Text] [Related]  

  • 19. From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.
    Warren MJ; Bass ES
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S167-70. PubMed ID: 23253762
    [No Abstract]   [Full Text] [Related]  

  • 20. An equal right to protection.
    Diallo DD; Forbes A
    Posit Aware; 2013; 25(5):12-4. PubMed ID: 25358201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.